Asundexian Lowered Stroke Risk Without Increased Bleeding Complications
Bayer AG's investigational drug asundexian reduced recurrent stroke risk by 26% in patients who recently experienced a stroke or temporary blockage of blood flow.
Tag: cardiology and cardiovascular
All
Latest
Asundexian Lowered Stroke Risk Without Increased Bleeding Complications
Bayer AG’s investigational drug asundexian reduced recurrent stroke risk by 26% in patients who recently experienced a stroke or temporary blockage of blood flow.
Read More
Endovascular Therapy Improved QoL for DVT Patients with Chronic Blood Clot Complications
A clinical trial found that minimally invasive endovascular therapy reduces symptoms of post-thrombotic syndrome after deep vein thrombosis.
Read More
Sleep Apnea Linked to Oxidative Stress Markers
Obstructive sleep apnea and oxidative stress share a bidirectional relationship, influencing disease progression and antioxidant responses.
Read More
First AHA/ACC Guidelines for Managing Pulmonary Embolism
The American Heart Association and American College of Cardiology issued their first joint clinical practice recommendations for acute pulmonary embolism.
Read More
Age-related Stiffening of Pulmonary Artery Tied to Dyspnea
The pulmonary artery progressively stiffens with age, which may contribute to unexplained dyspnea in older adults.
Read More
Concern Over Preparedness for Teen Cardiac Emergencies
A national parent poll reports gaps in community preparedness for teen cardiac emergencies and concerns about school readiness.
Read More
Link Between Influenza and Heart Disease
The influenza A virus exploits specific immune cells to infiltrate the heart and damage heart muscle cells.
Read More
Half of Commercially Insured Patients Have Chronic Conditions
The majority (57.5%) of commercially insured patients had at least one chronic condition in 2024, with high cholesterol the most common affliction.
Read More
Older Women Less Likely to Receive ER Morphine for Chest Pain
Women over age 57 are less likely to receive IV morphine in the emergency room when presenting with chest pain, compared to younger women, younger men, and older men.
Read More
Cardiovascular Risk Drops After Quitting Smoking
Cigarette smoking increased cardiovascular risks at 2-5 cigarettes daily, but cessation rapidly lowered risk within ten years, overall.
Read More
Case Report: Novel Treatment for Fibrosing Mediastinitis
A new case report describes a novel approach for treating fibrosing mediastinitis using rituximab injections directly into mediastinal lymph nodes combined with pulmonary artery angioplasty.
Read More
FDA Clears HeartBeam Cable-free 12-lead ECG
HeartBeam’s 12-lead ECG synthesis software allows patients to obtain an ECG reading for their arrhythmia from the comfort of home, with results promptly reviewed by an on-demand, board-certified cardiologist.
Read More
Pneumonia-related Bacterial Enzyme Causes Fatal Heart Conditions
A pneumococcal enzyme, zmpB, is a key factor in some pneumonia patients develop serious heart complications.
Read More
Zoll Completes Launch of LifeVest WCD Garment
Zoll has completed the US rollout of its next generation garment for the LifeVest wearable cardioverter defibrillator (WCD), according to the company.
Read More
Updated CPR, Emergency CV Care Guidelines for Pediatric and Neonatal Resuscitation
New guidelines from the AAP/AHA update procedures for pediatric and neonatal CPR and emergency cardiovascular care for the first time since 2020.
Read More
GLP-1 RAs Versus SGLT2 Inhibitors for Heart Failure Risk in PAH
GLP-1 RAs may provide added benefit over SGLT2-i in protecting right heart function among patients with PAH.
Read More
COVID-19 Ages Blood Vessels, Especially in Women
Blood vessels gradually become stiffer with age, but the new study suggests that COVID-19 could accelerate this process.
Read More
CPAP Has Cardiovascular Benefits for Some, Not for Others
The data suggests that CPAP may offer long-term cardiovascular benefit in people with high-risk OSA but may have unintended harmful effects in those without high-risk OSA.
Read More
ESC Calls for EU Action on All Nicotine Products
The European Society of Cardiology (ESC) has called for the European Union to apply higher excise taxes, advertising bans, and indoor-use restrictions to all nicotine products.
Read More
Optimal Heart Health in Children Cuts Risk of Chronic Diseases in Adulthood
Benefits include lower risks of cancer, dementia, lung disease, liver disease, kidney disease, type 2 diabetes, obesity, depression and hearing loss, as well as better cognitive, dental and eye health.
Read More
Pandemic Increased Mental Disorders, Malaria, Heart Disease
Disrupted care during the COVID-19 pandemic led to sharp increases in other non-COVID causes of illness and death, particularly mental health disorders, malaria in young children, and stroke and heart disease in older adults.
Read More
ESC Advocates Vaccination for Cardiovascular Prevention
A new ESC Clinical Consensus Statement reports on the beneficial effects of vaccines in reducing cardiovascular events following various viral and bacterial infections, particularly in at-risk patient groups.
Read More
Cannabis Use Doubles Risk of Cardiovascular Disease Mortality
Cannabis use is linked to a doubled risk of cardiovascular disease mortality, with significantly heightened risks of having a stroke or acute coronary syndrome.
Read More
Online Education Enhanced Clinical Guideline Use in Atrial Fibrillation
Online education for health professionals increased patient-level adherence to optimal care recommendations for rhythm control by 51% compared to centers with no additional education.
Read More